Skip to content

Clinical trials

Phase 1 Leukemia, B-Cell trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Phase: Phase 1 Status: Unknown status Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20172
20183
20192
20202
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
iCell Gene Therapeutics2
Athenex, Inc.1
Beijing Immunochina Medical Science & Technology Co., Ltd.1
Chinese PLA General Hospital1
Henan Cancer Hospital1
Immune Cell, Inc.1
NovalGen Ltd.1
PersonGen BioTherapeutics (Suzhou) Co., Ltd.1
The First People's Hospital of Yunnan1
XEME Biopharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell14
Lymphoma, B-Cell6
Recurrence3
Burkitt Lymphoma2
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Carcinoma, Non-Small-Cell Lung1
Dendritic Cell Sarcoma, Interdigitating1
Lymphoma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.